Searchable abstracts of presentations at key conferences on calcified tissues

ba0003pp324 | Osteoporosis: treatment | ECTS2014

The effects of risk factors on raloxifene, alendronate, and vitamin D treatment in postmenopausal osteoporosis

Somekawa Yoshiaki , Fusegi Atsusi , Okamoto Chiaki , Sekigawa Kana , Tsugata Mikiko , Umeki Hidenori

Objective: The purpose of this study was to compare the efficacy of raloxifene (RLX) 60 mg daily, vitamin D (VD) 200 IU daily, and alendronate (ALN) 35 mg once weekly on bone mineral density (BMD) of lumbar spine (L) and total femur (F) in postmenopausal women with osteoporosis, and the effects of the osteoporosis risk factors on BMDs and these treatments.Design and methods: The subjects were 242 postmenopausal Japanese women aged 48–87 years (mean ...